If this email is not displaying properly or to share with a colleague, please View as Webpage
|
|
Warm Hand-Off from ORN to PCSS Helps New York Practice Develop OUD Treatment Implementation
|
|
 |
Madeline Haas, MD, a primary care provider for Albany Family Medicine, wanted to increase the number of opioid use disorder patients the practice treats, so she turned to the Opioid Response Network (ORN). ORN, a grant funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), provides localized technical assistance (TA) to state agencies, healthcare systems, communities and individuals.
Aimee Campbell, PhD, lead implementation scientist for ORN, was called upon to respond to this TA request. Through discussions with Dr. Haas, it became clear that her practice would be a perfect fit for a more comprehensive approach that Dr Campbell was leading through
Providers Clinical Support System
|
|
|
|
Madeline Haas, MD, is
Albany Family Medicine's
PCSS Champion
(PCSS), another SAMHSA grant initiative. Both grants are led by the AAAP and work collaboratively to duplication and benefit from support and resources across efforts.
|
|
|
|
PCSS-Exchange Session 5: Implement and Sustain, Part 1
|
|
Session 5 of the PCSS-Exchange (PCSS-X) is scheduled for Jan. 21 at 3:00 pm ET. Don't worry if you missed the first four sessions; you can join any time. Note: Sessions are not recorded.
This session will discuss key considerations for patient initiation (induction) and on-going visits, including lab guidelines. The session will address the clinical management of patients with continued opioid use, poly-substance use, and comorbid mental health conditions.
PCSS-X is intended for an interprofessional audience, and participants are welcome to attend whichever sessions are most relevant to their current situation. Prescribers with frontline experience prescribing MAT and developing clinic workflows will be available during each session to answer participants’ questions and discuss real-world cases.
|
|
Quality Medical Care for People Who Use Drugs
Time: 1:00 pm - 2:00 pm ET
Date: Thursday, January 14, 2021
Presenters: Brad Finegood, MA; Judith Tsui, MD, MPH; Shireesha Dhanireddy, MD; Richard Waters, MD
Sponsoring organization: National Council for Behavioral Health
About the webinar: Leading Seattle-area physicians discuss how quality medical care intersects with harm reduction philosophy and practice. Learn how medical providers have advanced opportunities for recovery from substance use disorders by providing compassionate care to people who use drugs and partnering with harm reduction services providers. [Learn more]
|
|
Barriers and Facilitators to Buprenorphine Prescribing by Nurse Practitioners
Time: 1:00 pm - 2:00 pm ET
Date: Wednesday, January 20, 2021
Presenter: Chandra Speight, NP
Sponsoring organization: American Society for Pain Management Nursing
About the webinar: Save the date. Registration coming soon! [Learn more]
|
|
All PCSS webinars are recorded and are available for on demand viewing, usually within two weeks of live webinar (and often sooner). Recent webinars that are now available: |
|
(American Psychiatric Association)
(National Council for Behavioral Health)
(American Psychiatric Association)
|
|
PCSS Clinical Roundtables |
|
Upcoming PCSS Clinical Roundtables:
Jan. 19, 12:00 pm - 1:00 pm
Jan. 28, 3:00 pm - 4:00 pm
Feb. 1, 1:00 pm - 2:00 pm
Credit Designations Available: AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.
* All times are ET
|
|
New Model State Parity Legislation
Named in Honor of Former U.S. Rep. Jim Ramstad
|
|
Tool will help policymakers increase access to mental health and addiction care amid historic rates of overdoses and suicides across the nation. [Learn more]
|
|
Toolkit: Overdose Prevention, Harm Reduction,
and Treatment for Substance Use Disorders
Opioid and death is a national epidemic, involving both prescription opioid pain medications, and illicit opioids such as heroin, illicit fentanyl, and fentanyl analogs. In addition,
overdoses involving stimulants such as methamphetamine, cocaine, and prescription stimulants (often mixed with illicit fentanyl) are increasing. This toolkit was developed to provide resources that physicians, physician assistants, and other healthcare providers can use to help reverse the overdose epidemic in Oregon but has useful information for anyone.
|
|
Medicaid Programs Now Required to Provide and Cover
MAT and Behavioral Therapy for OUD
|
|
Pursuant to Section 1006(b) of the SUPPORT for Patients and Communities Act, the Center for Medicaid sent a State Health Official letter providing guidance on implementation of the provision throughout the program. Within the scope of the SUPPORT Act provision, state Medicaid programs are now required to provide and cover medication-assisted treatment (MAT) and behavioral therapy for opioid use disorders. [Learn more]
|
|
Medicaid Improves MAT Access for Two States |
|
The Centers for Medicare & Medicaid Services (CMS) announced the approval of both the Oklahoma and Maine section 1115 demonstrations to expand treatment for substance abuse disorder. CMS approved Oklahoma’s new demonstration, titled “Institutions for Mental Diseases Waiver for Serious Mental Illness/Substance Use Disorder,” and Maine’s new demonstration, entitled “Maine Substance Use Disorder (SUD) Care Initiative.” [Learn more]
|
|
JAMA Pediatrics
JAMA Psychiatry
Journal of Substance Abuse Treatment
Pediatrics
|
|
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
|
|
|
|
|
|
|
